rs34885143

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1BS2_Supporting

The NM_001370658.1(BTD):​c.73G>A​(p.Gly25Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0136 in 1,614,134 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.010 ( 13 hom., cov: 32)
Exomes 𝑓: 0.014 ( 156 hom. )

Consequence

BTD
NM_001370658.1 missense

Scores

1
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:9

Conservation

PhyloP100: -0.0140
Variant links:
Genes affected
BTD (HGNC:1122): (biotinidase) The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005297005).
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.014 (20455/1461890) while in subpopulation NFE AF= 0.0161 (17863/1112008). AF 95% confidence interval is 0.0159. There are 156 homozygotes in gnomad4_exome. There are 9951 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BTDNM_001370658.1 linkuse as main transcriptc.73G>A p.Gly25Arg missense_variant 2/4 ENST00000643237.3 NP_001357587.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BTDENST00000643237.3 linkuse as main transcriptc.73G>A p.Gly25Arg missense_variant 2/4 NM_001370658.1 ENSP00000495254 P1P43251-4

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1534
AN:
152126
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00234
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00439
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.0274
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0155
Gnomad OTH
AF:
0.00431
GnomAD3 exomes
AF:
0.0102
AC:
2560
AN:
251422
Hom.:
20
AF XY:
0.0101
AC XY:
1379
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.00240
Gnomad AMR exome
AF:
0.00353
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00418
Gnomad FIN exome
AF:
0.0240
Gnomad NFE exome
AF:
0.0148
Gnomad OTH exome
AF:
0.0108
GnomAD4 exome
AF:
0.0140
AC:
20455
AN:
1461890
Hom.:
156
Cov.:
32
AF XY:
0.0137
AC XY:
9951
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.00206
Gnomad4 AMR exome
AF:
0.00373
Gnomad4 ASJ exome
AF:
0.000306
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.00435
Gnomad4 FIN exome
AF:
0.0246
Gnomad4 NFE exome
AF:
0.0161
Gnomad4 OTH exome
AF:
0.0106
GnomAD4 genome
AF:
0.0101
AC:
1535
AN:
152244
Hom.:
13
Cov.:
32
AF XY:
0.00997
AC XY:
742
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.00233
Gnomad4 AMR
AF:
0.00438
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00311
Gnomad4 FIN
AF:
0.0274
Gnomad4 NFE
AF:
0.0155
Gnomad4 OTH
AF:
0.00426
Alfa
AF:
0.0136
Hom.:
24
Bravo
AF:
0.00868
TwinsUK
AF:
0.0135
AC:
50
ALSPAC
AF:
0.0148
AC:
57
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.0159
AC:
137
ExAC
AF:
0.00995
AC:
1208
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0134
EpiControl
AF:
0.0122

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Biotinidase deficiency Uncertain:1Benign:4
Uncertain significance, criteria provided, single submitterclinical testingElsea Laboratory, Baylor College of MedicineApr 01, 2020- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalMay 04, 2023European Non-Finnish population allele frequency is 1.469% (rs34885143, 1052/69016 alleles, 11 homozygotes in gnomAD v3.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.4.0, this variant is classified as BENIGN. Following criteria are met: BA1 -
Benign, no assertion criteria providedclinical testingNatera, Inc.Jun 23, 2020- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
not provided Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 04, 2017- -
Likely benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoNov 21, 2020- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 03, 2021This variant is associated with the following publications: (PMID: 26361991, 12359137, 27329734, 25087612, 21228398, 10400129, 15060693, 15776412, 11668630, 26810761, 16150625, 26990548, 27657684, 31664448) -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024BTD: BP4, BS1, BS2 -
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2016- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 18, 2022- -
BTD-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 03, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
1.6
DANN
Benign
0.81
DEOGEN2
Benign
0.26
.;.;T;.;.;.;.;T;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.60
.;T;T;.;T;.;T;T;T;T
MetaRNN
Benign
0.0053
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
0.69
.;.;N;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.22
T
PROVEAN
Pathogenic
-5.0
D;N;.;.;.;.;N;N;N;.
REVEL
Uncertain
0.43
Sift
Benign
0.11
T;T;.;.;.;.;T;T;T;.
Sift4G
Benign
0.43
T;T;.;.;.;.;T;T;T;.
Polyphen
0.0010
.;.;B;.;.;.;.;.;.;.
Vest4
0.15, 0.15, 0.16
MutPred
0.74
.;.;Gain of phosphorylation at S48 (P = 0.0901);.;Gain of phosphorylation at S48 (P = 0.0901);.;.;.;.;.;
MPC
0.084
ClinPred
0.013
T
GERP RS
-0.69
Varity_R
0.032
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34885143; hg19: chr3-15677019; API